Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 6,771

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications

Gupta, Ajay Kumar, Gupta, Mona·2005·Biomaterials

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2004.10.012

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 231

  1. Moghimi, 2001, Long-circulating and target-specific nanoparticles, Pharm Rev, 53, 283, 10.1016/S0031-6997(24)01494-7 · DOI · Paper page
  2. Curtis, 2001, Nanotechniques and approaches in biotechnology, Trends Biotech, 19, 97, 10.1016/S0167-7799(00)01536-5 · DOI · Paper page
  3. Wilkinson, 2003, Nanotechnology applications in medicine, Med Device Technol, 14, 29
  4. Panyam, 2003, Biodegradable nanoparticles for drug and gene delivery to cells and tissue, Adv Drug Del Rev, 55, 329, 10.1016/S0169-409X(02)00228-4 · DOI · Paper page
  5. Siegel RW. In: Siegel RW, Hu E, Roco MC editors. Nanostructure science and technology. A worldwide study. WTEC, Loyola College in Maryland; 1999. · DOI · Paper page
  6. Uchegbu, 1996, Adverse drug events related to dosage forms and delivery systems, Drug Saf, 14, 39, 10.2165/00002018-199614010-00005 · DOI
  7. Gilchrist, 1957, Selective inductive heating of lymph nodes, Ann Surg, 146, 596, 10.1097/00000658-195710000-00007 · DOI · Paper page
  8. Kwei, 1990, Structure and valence from complementary anomalous X-ray and neutron powder diffraction, J Molecul Struct, 223, 383, 10.1016/0022-2860(90)80482-Y · doi:10.1016/0022-2860(90)80482-y
  9. Babincova, 2001, High-gradient magnetic capture of ferrofluids, Z Naturforsch (Sect C), 56, 909, 10.1515/znc-2001-9-1039 · doi:10.1515/znc-2001-9-1039
  10. Bonnemain, 1998, Superparamagnetic agents in magnetic resonance imaging, J Drug Target, 6, 167, 10.3109/10611869808997890 · DOI · Paper page
  11. Babes, 1999, Synthesis of iron oxide nanoparticles used as MRI contrast agents, J Coll Int Sci, 212, 474, 10.1006/jcis.1998.6053 · DOI · Paper page
  12. Goya, 2003, Static and dynamic magnetic properties of spherical magnetite nanoparticles, J Appl Phys, 94, 3520, 10.1063/1.1599959 · DOI · Paper page
  13. Arbab, 2003, Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging, Radiology, 229, 838, 10.1148/radiol.2293021215 · DOI · Paper page
  14. Reimer, 1996, Development and experimental application of receptor-specific MR contrast media, Radiology, 36, 153, 10.1007/s001170050053 · doi:10.1007/s001170050053
  15. Pankhurst, 2003, Applications of magnetic nanoparticles in biomedicine, J Phys D, 36, R167, 10.1088/0022-3727/36/13/201 · DOI · Paper page
  16. Berry, 2003, Functionalisation of magnetic nanoparticles for applications in biomedicine, J Phys D, 36, R198, 10.1088/0022-3727/36/13/203 · DOI · Paper page
  17. Tartaj, 2003, The preparation of magnetic nanoparticles for applications in biomedicine, J Phys D, 36, R182, 10.1088/0022-3727/36/13/202 · DOI · Paper page
  18. Jordan, 2001, Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia, J Magn Magn Mater, 225, 118, 10.1016/S0304-8853(00)01239-7 · DOI · Paper page
  19. Chatterjee, 2003, Size dependent magnetic properties of iron oxide nanoparticles, J Magn Magn Mater, 257, 113, 10.1016/S0304-8853(02)01066-1 · DOI · Paper page
  20. Pratsinis, 1996, Particle formation in gases—a review, Powder Technol, 88, 267, 10.1016/S0032-5910(96)03130-0 · doi:10.1016/s0032-5910(96)03130-0
  21. Stolnik, 1995, Long circulating microparticulate drug carriers, Adv Drug Del Rev, 16, 195, 10.1016/0169-409X(95)00025-3 · DOI · Paper page
  22. Lee, 2001, Microelectromagnets for the control of magnetic nanoparticles, Appl Phys Lett, 79, 3308, 10.1063/1.1419049 · DOI · Paper page
  23. Rishton, 1997, Magnetic tunnel junctions fabricated at tenth-micron dimensions by electron beam lithography, Microelectron Eng, 35, 249, 10.1016/S0167-9317(96)00107-4 · DOI
  24. Gupta, 2004, Surface modified superparamagnetic nanoparticles for drug delivery, IEEE Trans Nanobiosci, 3, 66, 10.1109/TNB.2003.820277 · DOI · Paper page
  25. Gupta, 2004, Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors, Biomaterials, 25, 3029, 10.1016/j.biomaterials.2003.09.095 · DOI · Paper page
  26. Reimers, 1972, Preparing magnetic fluids by a peptizing method, US Bureau Mines Tech Rep, 59
  27. Hadjipanayis GC, Siegel RW. Nanophase materials: synthesis, properties and applications. NATO ASI Series, Applied Sciences, vol. E260. Dordrecht: Kluwer; 1993. · doi:10.1007/978-94-011-1076-1
  28. Sjogren, 1994, Magnetic characterization of iron oxides for magnetic resonance imaging, Magn Reson Med, 31, 268, 10.1002/mrm.1910310305 · DOI
  29. Kim, 2001, Synthesis and characterization of surfactant-coated superparamagnetic monodispersed iron oxide nanoparticles, J Magn Magn Mater, 225, 30, 10.1016/S0304-8853(00)01224-5 · DOI · Paper page
  30. Boistelle, 1988, Crystallization mechanisms in solution, J Cryst Growth, 90, 14, 10.1016/0022-0248(88)90294-1 · DOI · Paper page
  31. Banfield, 2000, Aggregation-based crystal growth and microstructure development in natural iron oxyhydroxide biomineralization products, Science, 289, 751, 10.1126/science.289.5480.751 · DOI · Paper page
  32. Penn, 1998, Imperfect oriented attachment, Science, 281, 969, 10.1126/science.281.5379.969 · DOI · Paper page
  33. Penn, 1999, Morphology development and crystal growth in nanocrystalline aggregates under hydrothermal conditions, Geochim Cosmochim Acta, 63, 1549, 10.1016/S0016-7037(99)00037-X · DOI · Paper page
  34. Chemseddine, 1999, Nanostructuring Titania, Eur J Inorg Chem, 2, 235, 10.1002/(SICI)1099-0682(19990202)1999:2<235::AID-EJIC235>3.0.CO;2-N · DOI · Paper page
  35. Verges, 1990, Formation of rod-like zinc oxide microcrystals in homogenous solutions, J Chem Soc Faraday Trans, 86, 959, 10.1039/FT9908600959 · doi:10.1039/ft9908600959
  36. Taylor, 2001, Structural and morphological anomalies in magnetosomes, J Microsc, 201, 84, 10.1046/j.1365-2818.2001.00760.x · DOI
  37. Zhou, 2001, Granular growth of Fe3O4 thin films and its antiphase boundaries prepared by pulsed laser deposition, J Appl Phys, 89, 7398, 10.1063/1.1358831 · doi:10.1063/1.1358831
  38. Kim, 2001, Superparamagnetic iron oxide nanoparticles for bio-medical applications, Scr Mater, 44, 1713, 10.1016/S1359-6462(01)00870-3 · DOI
  39. Binh, 1998, Nanotips and nanomagnetism, Appl Surf Sci, 130–132, 803, 10.1016/S0169-4332(98)00158-5 · DOI
  40. Coey, 1971, Noncollinear spin arrangement in ultrafine ferrimagnetic crystallites, Phys Rev Lett, 27, 1140, 10.1103/PhysRevLett.27.1140 · doi:10.1103/physrevlett.27.1140
  41. Varanda, 2002, Structural and magnetic transformation of monodispersed iron oxide particles in a reducing atmosphere, J Appl Phys, 92, 2079, 10.1063/1.1496124 · doi:10.1063/1.1496124
  42. Held, 2001, Competing interactions in dispersions of superparamagnetic nanoparticles, Phys Rev, B 64, 12408, 10.1103/PhysRevB.64.012408 · DOI
  43. Collier JH, Messersmith PB. Biomimetic mineralization, mesoporous structures, Encyclopedia Mater Sci Technol 2001;602–6. · DOI
  44. Sinha, 2000, Synthesis of organized inorganic crystal assemblies, Curr Sci, 79, 646
  45. Rosensweig RE. Ferrohydrodynamics. Cambridge: 1985.
  46. Tillotson, 2001, Nanostructured energetic materials using sol–gel methodologies, J Non-Cryst Solids, 285, 335, 10.1016/S0022-3093(01)00477-X · DOI · Paper page
  47. Ziolo, 1992, Matrix mediated synthesis of γ-Fe2O3, Science, 257, 219, 10.1126/science.257.5067.219 · DOI · Paper page
  48. Deng, 2003, Preparation of magnetic polymeric particles via inverse microemulsion polymerization process, J Magn Magn Mater, 257, 69, 10.1016/S0304-8853(02)00987-3 · DOI
  49. Santra, 2001, Synthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion, Langmuir, 17, 2900, 10.1021/la0008636 · DOI · Paper page
  50. Li, 2000, Structured materials synthesis in a self-assembled surfactant mesophase, Colloids Surf A, 174, 275, 10.1016/S0927-7757(00)00538-0 · doi:10.1016/s0927-7757(00)00538-0
  51. Okamura, 2001, A magnetosome-specific GTPase from the magnetic bacterium Magnetospirillum magneticum AMB-1, J Biol Chem, 276, 48183, 10.1074/jbc.M106408200 · DOI
  52. Yaacob, 1994, Synthesis and characterization of magnetic nanoparticles in spontaneously generated vesicles, J Coll Int Sci, 168, 289, 10.1006/jcis.1994.1423 · doi:10.1006/jcis.1994.1423
  53. Bagwe, 2001, Improved drug delivery using microemulsions, Crit Rev Ther Drug Carrier Syst, 18, 77
  54. Lawrence, 1994, Surfactant systems, Eur J Drug Metab Pharmacokinet, 19, 257, 10.1007/BF03188929 · doi:10.1007/bf03188929
  55. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 45(1) 89–121 · DOI · Paper page
  56. Fendler, 1987, Atomic and molecular clusters in membrane mimetic chemistry, Chem Rev, 87, 877, 10.1021/cr00081a002 · DOI · Paper page
  57. Sugimoto, 1987, Preparation of monodispersed colloidal particles, Adv Coll Int Sci, 28, 65, 10.1016/0001-8686(87)80009-X · DOI · Paper page
  58. Tang, 2003, Magnetite Fe3O4 nanocrystals, J Phys Chem B, 107, 7501, 10.1021/jp027048e · DOI · Paper page
  59. Muller, 1984, Particle size distributions and particle size alterations in microemulsions, J Pharm Sci, 73, 919, 10.1002/jps.2600730714 · doi:10.1002/jps.2600730714
  60. Munshi, 1997, Size modulation of polymeric nanoparticles under controlled dynamics of microemulsion droplets, J Colloid Interface Sci, 190, 387, 10.1006/jcis.1997.4889 · DOI
  61. Igartua, 2002, Development and characterization of solid lipid nanoparticles loaded with magnetite, Int J Pharm, 233, 149, 10.1016/S0378-5173(01)00936-X · doi:10.1016/s0378-5173(01)00936-x
  62. Bhandarkar, 1990, Synthesis of nanocomposite particles by intravesicular coprecipitation, J Coll Int Sci, 139, 541, 10.1016/0021-9797(90)90127-A · doi:10.1016/0021-9797(90)90127-a
  63. Shibli, 2001, The effect of the ferrofluid magnetic particle concentration on the thermal diffusivity, Braz J Phys, 31, 418, 10.1590/S0103-97332001000300012 · doi:10.1590/s0103-97332001000300012
  64. Yaacob, 1995, Magnetic nanoparticles produced in spontaneous cationic–anionic vesicles—room temperature synthesis and characterization, J Coll Interf Sci, 171, 73, 10.1006/jcis.1995.1152 · doi:10.1006/jcis.1995.1152
  65. Bailey, 1983, Lesser known applications of ferrofluids, J Magn Magn Mater, 39, 178, 10.1016/0304-8853(83)90428-6 · doi:10.1016/0304-8853(83)90428-6
  66. Charles, 1980, Progress in the development of ferromagnetic liquids, IEEE Trans Magn, 16, 172, 10.1109/TMAG.1980.1060584 · doi:10.1109/tmag.1980.1060584
  67. Khalafalla, 1980, Preparation of dilution-stable aqueous magnetic fluids, IEEE Trans Magnet, 16, 178, 10.1109/TMAG.1980.1060578 · DOI · Paper page
  68. Hamley, 2003, Nanotechnology with soft materials, Angew Chem Int Ed, 42, 1692, 10.1002/anie.200200546 · DOI · Paper page
  69. Tepper, 2003, Magneto-optical properties of iron oxide films, J Appl Phys, 93, 6948, 10.1063/1.1540033 · DOI
  70. Mendenhall, 1996, Optimization of long-term stability of magnetic fluids from magnetite and synthetic polyelectrolytes, J Coll Interf Sci, 184, 519, 10.1006/jcis.1996.0647 · DOI
  71. Salzman, 1983, Polyethyleneglycol oxide as a biomaterial, Am J Soc Artif Intern Organs, 6, 60
  72. Yu, 2003, Structure and magnetic properties of SiO2 coated Fe2O3 nanoparticles synthesized by chemical vapor condensation process, Rev Adv Mater Sci, 4, 55
  73. Miller, 1983, Morphological changes of ethylene/vinyl acetate based on controlled delivery systems during release of water-soluble solutes, J Memb Sci, 14, 79, 10.1016/S0376-7388(00)81375-7 · DOI
  74. Zhao, 1998, Novel degradable poly(ethylene glycol) hydrogels for controlled release of protein, J Pharm Sci, 87, 1450, 10.1021/js980065o · DOI
  75. Ruiz, 1991, In vivo peptide release from poly(lactic-co-glycolic acid) copolymer 50/50 microspheres, J Cont Rel, 16, 177, 10.1016/0168-3659(91)90041-B · doi:10.1016/0168-3659(91)90041-b
  76. Li, 1997, A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery, J Pharm Sci, 86, 891, 10.1021/js970084i · DOI
  77. Akiyoshi, 1996, Supramolecular assembly of hydrophobized polysaccharides, Supramol Sci, 3, 157, 10.1016/0968-5677(96)00031-4 · doi:10.1016/0968-5677(96)00031-4
  78. Jeong, 1999, Self assembling nanospheres of hydrophobized pullulans in water, Drug Dev Ind Pharm, 25, 917, 10.1081/DDC-100102252 · DOI
  79. Schwick, 1969, Immunochemistry and immunology of collagen and gelatin, Bibliotheca Haematol, 3, 111
  80. Massia, 2000, Surface immobilized dextran limits cell adhesion and spreading, Biomaterials, 21, 2253, 10.1016/S0142-9612(00)00151-4 · DOI · Paper page
  81. Denizot, 1999, Phosphorylcholine coating of iron oxide nanoparticles, J Coll Interf Sci, 209, 66, 10.1006/jcis.1998.5850 · DOI
  82. Dresco, 1999, Preparation and properties of magnetite and polymer magnetite nanoparticles, Langmuir, 15, 1945, 10.1021/la980971g · DOI · Paper page
  83. Vladimir, 1999, Physical and chemical properties of magnetite and magnetite-polymer nanoparticles and their colloidal dispersions, J Coll Interf Sci, 212, 49, 10.1006/jcis.1998.5993 · DOI · Paper page
  84. Yee, 1999, Self assembled monolayers of alkanesulfonic and phosphonic acids on amorphous iron oxide nanoparticles, Langmuir, 15, 7111, 10.1021/la990663y · DOI · Paper page
  85. Sahoo, 2001, Alkyl phosphonate/phosphate coating on magnetite nanoparticles, Langmuir, 17, 7907, 10.1021/la010703+ · DOI · Paper page
  86. Rosensweig, 1969, Viscosity of magnetic fluid in a magnetic field, J Colloid Interf Sci, 29, 680, 10.1016/0021-9797(69)90220-3 · DOI · Paper page
  87. Tadmor, 2000, Resolving the puzzle of ferrofluid dispersants, Langmuir, 16, 9117, 10.1021/la0009137 · DOI
  88. Janik, 1997, Shear of molecularly confined liquid crystals. 1. Orientation and transition under confinement, Langmuir, 13, 4466, 10.1021/la960452i · DOI
  89. Klein, 1991, Forces between polymer-bearing surfaces undergoing shear, Nature, 352, 143, 10.1038/352143a0 · DOI · Paper page
  90. Portet, 2001, Nonpolymeric coatings of iron oxide colloids for biological use as magnetic resonance imaging contrast agents, J Coll Interf Sci, 238, 37, 10.1006/jcis.2001.7500 · DOI · Paper page
  91. Berry, 2003, Dextran and albumin derivatised iron oxide nanoparticles, Biomaterials, 24, 4551, 10.1016/S0142-9612(03)00237-0 · DOI · Paper page
  92. Gupta, 1989, Magnetically controlled targeted micro-carrier systems, Life Sci, 44, 175, 10.1016/0024-3205(89)90593-6 · DOI · Paper page
  93. Ugelstad, 1993, Monodisperse magnetic polymer particles. New biochemical and biomedical applications, Blood Purif, 11, 349, 10.1159/000170129 · doi:10.1159/000170129
  94. Kawaguchi, 1996, Modification and functionalization of hydrogel microspheres, Colloids & Surfaces A Physicochem Eng Aspects, 109, 147, 10.1016/0927-7757(95)03482-X · doi:10.1016/0927-7757(95)03482-x
  95. Sauzedde, 1999, Hydrophilic magnetic polymer latexes 1. Adsorption of magnetic iron oxide nanoparticles onto various cationic latexes, Colloid Polym Sci, 277, 846, 10.1007/s003960050461 · DOI · Paper page
  96. Sauzedde, 1999, Hydrophilic magnetic polymer latexes 2. Encapsulation of adsorbed iron oxide nanoparticles, Colloid Polym Sci, 277, 1041, 10.1007/s003960050488 · doi:10.1007/s003960050488
  97. Furusawa, 1994, Synthetic process to control the total size and component distribution of multilayer magnetic composite particles, Colloid Polym Sci, 272, 1104, 10.1007/BF00652379 · DOI
  98. Chatterjee, 2001, Modification and characterization of polystyrene-based magnetic microspheres and comparison with albumin-based magnetic microspheres, J Magn Magn Mater, 225, 21, 10.1016/S0304-8853(00)01223-3 · DOI
  99. Lee, 1996, Preparation of ultrafine Fe3O4 particles by precipitation in the presence of PVA at high pH, J Coll Interf Sci, 490, 10.1006/jcis.1996.0062 · DOI · Paper page
  100. Ng, 2002, Nanostructure array fabrication with temperature-controlled self-assembly techniques, Nanotechnology, 13, 554, 10.1088/0957-4484/13/5/302 · doi:10.1088/0957-4484/13/5/302
  101. Kataby, 1998, Coating of amorphous iron nanoparticles by long-chain alcohols, Langmuir, 14, 1512, 10.1021/la970978i · doi:10.1021/la970978i
  102. Capek, 2001, Microemulsion polymerization of styrene in the presence of a cationic emulsifier, Adv Colloid Interf Sci, 92, 195, 10.1016/S0001-8686(00)00072-5 · doi:10.1016/s0001-8686(00)00072-5
  103. Torchilin, 1995, Which polymers can make nanoparticulate drug carriers long-circulating, Adv Drug Del Rev, 16, 141, 10.1016/0169-409X(95)00022-Y · DOI · Paper page
  104. Florence, 1997, The oral absorption of micro- and nanoparticulates, Pharm Res, 14, 259, 10.1023/A:1012029517394 · DOI · Paper page
  105. Chen, 2003, Gold-coated iron nanoparticles for biomedical applications, J Appl Phys, 93, 7551, 10.1063/1.1555312 · DOI · Paper page
  106. Lin, 2001, Gold-coated iron (Fe@Au) nanoparticles, J Solid State Chem, 159, 26, 10.1006/jssc.2001.9117 · DOI · Paper page
  107. Carpenter, 2001, Iron nanoparticles as potential magnetic carriers, J Magn Magn Mater, 225, 17, 10.1016/S0304-8853(00)01222-1 · DOI · Paper page
  108. Zhou, 2001, Nanostructures of gold coated iron core-shell nanoparticles and the nanobands assembled under magnetic field, Eur Phys J D, 16, 289, 10.1007/s100530170112 · DOI
  109. Ulman, 1996, Formation and structure of self-assembled monolayers, Chem Rev, 96, 1533, 10.1021/cr9502357 · DOI · Paper page
  110. Mulvaney, 2000, Silica encapsulation of quantum dots and metal clusters, J Mater Chem, 10, 1259, 10.1039/b000136h · DOI · Paper page
  111. Tartaj, 2002, Synthesis of nanomagnets dispersed in colloidal silica cages with applications in chemical separation, Langmuir, 18, 4556, 10.1021/la025566a · DOI
  112. Tartaj, 2001, Single-step nanoengineering of silica coated maghemite hollow spheres with tunable magnetic properties, Adv Mater, 13, 1620, 10.1002/1521-4095(200111)13:21<1620::AID-ADMA1620>3.0.CO;2-Z · doi:10.1002/1521-4095(200111)13:21<1620::aid-adma1620>3.0.co;2-z
  113. Santra, 2001, Synthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion, Langmuir, 17, 2900, 10.1021/la0008636 · DOI · Paper page
  114. Morawski, 2004, Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI, Magn Reson Med, 51, 480, 10.1002/mrm.20010 · DOI · Paper page
  115. Shepherd, 1970, A method of producing ferrofluid with gadolinium particles, J Phys D Appl Phys, 3, 1985, 10.1088/0022-3727/3/12/430 · DOI
  116. Xu, 1992, Aerosol synthesis of gadolinium iron garnet particles, J Mater Res, 7, 712, 10.1557/JMR.1992.0712 · DOI
  117. Roberts, 2002, Chemistry for peptide and protein PEGylation, Adv Drug Del Rev, 54, 459, 10.1016/S0169-409X(02)00022-4 · DOI · Paper page
  118. Sato, 1987, Magnetic properties of ultrafine ferrite particles, J Magn Magn Mater, 65, 252, 10.1016/0304-8853(87)90044-8 · DOI · Paper page
  119. Dormann, 1997, vol. 98, 283
  120. Lefebure, 1998, Monodisperse magnetic nanoparticles, J Mater Res, 10, 2975, 10.1557/JMR.1998.0407 · DOI · Paper page
  121. Bean, 1959, Superparamagnetism, J Appl Phys, 30, 120S, 10.1063/1.2185850 · DOI · Paper page
  122. Li, 2002, Hall magnetometry on a single iron nanoparticle, Appl Phys Lett, 80, 4644, 10.1063/1.1487921 · doi:10.1063/1.1487921
  123. Han DH, Wang JP, Luo HL. Crystallite size effect on saturation magnetization of fine ferrimagnetic particles. J Magn Magn Mater 136(1–2):176–82. · doi:10.1016/0304-8853(94)90462-6
  124. Tourinho, 1989, Synthesis and magnetic properties of manganese and cobalt ferrofluids, Prog Colloid Polym Sci, 79, 128, 10.1007/BFb0116198 · DOI
  125. Gomez-Lopera, 2001, Synthesis and characterization of spherical magnetite/biodegradable polymer composite particles, J Colloid Interf Sci, 240, 40, 10.1006/jcis.2001.7579 · DOI
  126. Voit, 2001, Magnetic behavior of coated superparamagnetic iron oxide nanoparticles in ferrofluids, Mater Res Soc Symp Proc, 676, Y7.8.1, 10.1557/PROC-676-Y7.8 · doi:10.1557/proc-676-y7.8
  127. Bradbury, 1984, Magnetic size determination for interacting fine particle systems, IEEE Trans Magn, 20, 1846, 10.1109/TMAG.1984.1063338 · doi:10.1109/tmag.1984.1063338
  128. Olsvik, 1994, Magnetic separation techniques in diagnostic microbiology, Clin Microbiol Rev, 7, 43, 10.1128/CMR.7.1.43 · DOI · Paper page
  129. Yeh, 1993, Intracellular labeling of T-cells with superparamagnetic contrast agents, Magn Reson Med, 30, 617, 10.1002/mrm.1910300513 · DOI
  130. Handgretinger, 1998, Isolation and transplantation of autologous peripheral CD34+progenitor cells highly purified by magnetic-activated cell sorting, Bone Marrow Transplant, 21, 987, 10.1038/sj.bmt.1701228 · doi:10.1038/sj.bmt.1701228
  131. Schoepf, 1998, Intracellular magnetic labelling of lymphocytes for in vivo trafficking studies, BioTechniques, 24, 642, 10.2144/98244rr01 · DOI
  132. Weissleder, 1997, Magnetically labelled cells can be detected by MR imaging, J Magn Reson Imaging, 7, 258, 10.1002/jmri.1880070140 · DOI · Paper page
  133. Qian, 2002, Targeted drug delivery via transferrin receptor-mediated endocytosis pathway, Pharmacol Rev, 54, 561, 10.1124/pr.54.4.561 · DOI · Paper page
  134. Cotter, 1995, Cell death (apoptosis) in cell culture systems, Trends Biotechnol, 13, 150, 10.1016/S0167-7799(00)88926-X · DOI
  135. Gupta AK, Curtis ASG. Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles: preparation, characterization and their influence on human dermal fibroblasts in culture. Proceedings of the 30th Annual Symposium of Controlled Release of Bioactive Materials, vol. 30, 2003. p. 788.
  136. Gupta, 2003, Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis, IEEE Trans Nanobiosci, 2, 256, 10.1109/TNB.2003.820279 · doi:10.1109/tnb.2003.820279
  137. Zola, 1994, Detection of receptors for cytokines and growth factors, Immunologist, 2, 47
  138. Florin, 1994, Adhesion forces between individual ligand–receptor pairs, Science, 264, 415, 10.1126/science.8153628 · DOI · Paper page
  139. Pierres, 1996, Measuring bonds between surface-associated molecules, J Immunol Methods, 196, 105, 10.1016/0022-1759(96)00103-2 · doi:10.1016/0022-1759(96)00103-2
  140. Winoto-Morbach, 1994, Magnetophoresis, J Clin Lab Anal, 8, 400, 10.1002/jcla.1860080610 · DOI
  141. Tchikov, 2001, Adhesion of immunomagnetic particles targeted to antigens and cytokine receptors on tumor cells determined by magnetophoresis, J Magn Magn Mater, 225, 285, 10.1016/S0304-8853(00)01252-X · doi:10.1016/s0304-8853(00)01252-x
  142. Massia, 2000, Surface immobilized dextran limits cell adhesion and spreading, Biomaterials, 21, 2253, 10.1016/S0142-9612(00)00151-4 · DOI · Paper page
  143. Bourke, 2003, Polymers derived from the amino acid l-tyrosine, Adv Drug Del Rev, 55, 447, 10.1016/S0169-409X(03)00038-3 · DOI · Paper page
  144. Brandley, 1998, Covalent attachment of an Arg-Gly-Asp sequence peptide to derivatizable polyacrylamide surfaces, Anal Biochem, 172, 270, 10.1016/0003-2697(88)90442-3 · doi:10.1016/0003-2697(88)90442-3
  145. Nakajima, 1990, Adsorption of plasma proteins on Arg-Gly-Asp-Ser peptide-immobilized poly(vinylalcohol) and ethylene-acrylic copolymer films, Polym J, 22, 985, 10.1295/polymj.22.985 · doi:10.1295/polymj.22.985
  146. Osterberg, 1993, Comparison of polysachharide and poly(ethylene glycol) coatings for reduction of protein adsorption on polystyrene surfaces, Colloids Surf A Physicochem Eng Asp, 77, 159, 10.1016/0927-7757(93)80112-R · DOI
  147. Frazier, 1997, In situ surface plasmon resonance analysis of dextran monolayer degradation by dextranase, Langmuir, 13, 7115, 10.1021/la970382v · doi:10.1021/la970382v
  148. Crepon, 1991, Enzymatic degradation and immunogenic properties of derivatized dextrans, Biomaterials, 12, 550, 10.1016/0142-9612(91)90049-G · doi:10.1016/0142-9612(91)90049-g
  149. Wilhelm, 2003, Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating, Biomaterials, 24, 1001, 10.1016/S0142-9612(02)00440-4 · DOI · Paper page
  150. Josephson, 1999, High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates, Bioconj Chem, 10, 186, 10.1021/bc980125h · DOI · Paper page
  151. Bulte, 2001, Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells, Nat Biotechnol, 19, 1141, 10.1038/nbt1201-1141 · DOI · Paper page
  152. Mutsaers, 1988, Surface charge of macrophages and their interaction with charged particles, J Leukoc Biol, 44, 17, 10.1002/jlb.44.1.17 · DOI
  153. Farquhar, 1978, Recovery of surface membrane in anterior pituitary cells variations in traffic detected with anionic and cationic ferritin, J Cell Biol, 77, R35, 10.1083/jcb.77.3.R35 · DOI · Paper page
  154. Ghinea, 1985, Anionized and cationized hemeundecapeptides as probes for cell surface charge and permeability studies, J Cell Biol, 100, 606, 10.1083/jcb.100.2.606 · DOI
  155. Miller, 1988, Liposome-cell interactions in vitro, Biochemistry, 37, 12875
  156. Josphson, 1990, A functionalised superparamagnetic iron oxide colloid as a receptor directed MR contrast agent, Magn Reson Imaging, 8, 637, 10.1016/0730-725X(90)90143-P · DOI
  157. Moore, 1998, Measuring transferrin receptor gene expression by NMR imaging, Biochim Biophys Acta, 1402, 239, 10.1016/S0167-4889(98)00002-0 · DOI · Paper page
  158. Bulte, 1999, Neurotransplantation of magnetically labeled oligodendrocyte progenitors, Proc Natl Acad Sci USA (online), 96, 15256, 10.1073/pnas.96.26.15256 · DOI · Paper page
  159. Weissleder, 1997, Magnetically labelled cells can be detected by MR imaging, Magn Reson Imaging, 7, 258, 10.1002/jmri.1880070140 · DOI · Paper page
  160. Berry, 2004, The influence of transferrin stabilised magnetic nanoparticles on human dermal fibroblasts in culture, Int J Pharm, 269, 211, 10.1016/j.ijpharm.2003.09.042 · DOI
  161. Zhao, 2002, Differential conjugation of Tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake, Bioconjug Chem, 13, 840, 10.1021/bc0255236 · DOI · Paper page
  162. Bhorade, 2000, Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a Hiv-Tat derived membrane translocation peptide, Bioconjug Chem, 11, 301, 10.1021/bc990168d · DOI · Paper page
  163. Moore, 2001, Human transferrin receptor gene as a marker gene for MR imaging, Radiology, 221, 244, 10.1148/radiol.2211001784 · DOI
  164. Nam, 2003, Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins, Science, 301, 1884, 10.1126/science.1088755 · DOI · Paper page
  165. Nam, 2002, Bio-barcodes based on oligonucleotide-modified nanoparticles, J Am Chem Soc, 124, 3820, 10.1021/ja0178766 · DOI · Paper page
  166. Storhoff, 1999, Programmed materials synthesis with DNA, Chem Rev, 99, 1849, 10.1021/cr970071p · DOI · Paper page
  167. Kemmner, 1992, Separation of tumor cells from a suspension of dissociated human colorectal carcinoma tissue by means of monoclonal antibody-coated magnetic beads, J Immunol Methods, 147, 197, 10.1016/S0022-1759(12)80008-1 · doi:10.1016/s0022-1759(12)80008-1
  168. Kronick, 1986, Use of superparamagnetic for isolation of cells, J Biochem Biophys Methods, 12, 73, 10.1016/0165-022X(86)90052-7 · doi:10.1016/0165-022x(86)90052-7
  169. Lobel, 2000, Temperature controlled CO2 laser welding of soft tissues, Lasers Surg Med, 26, 4, 10.1002/(SICI)1096-9101(2000)26:1<4::AID-LSM3>3.0.CO;2-J · doi:10.1002/(sici)1096-9101(2000)26:1<4::aid-lsm3>3.0.co;2-j
  170. Fried, 1999, Radiometric surface temperature measurements during dye-assisted laser skin closure, Lasers Surg Med, 25, 291, 10.1002/(SICI)1096-9101(1999)25:4<291::AID-LSM4>3.0.CO;2-# · DOI
  171. Xu, 2004, Strong and bioactive composites containing nano-silica-fused whiskers for bone repair, Biomaterials, 25, 4615, 10.1016/j.biomaterials.2003.12.058 · doi:10.1016/j.biomaterials.2003.12.058
  172. Sokolov, 2003, Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles, Cancer Res, 63, 1999
  173. Bulte, 2001, Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells, Nat Biotechnol, 19, 1141, 10.1038/nbt1201-1141 · DOI · Paper page
  174. Chouly, 1996, Development of superparamagnetic nanoparticles for MRI, J Microencapsul, 13, 245, 10.3109/02652049609026013 · DOI · Paper page
  175. Storm, 1995, Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system, Adv Drug Del Rev, 17, 31, 10.1016/0169-409X(95)00039-A · DOI · Paper page
  176. Zhang, 2002, Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake, Biomaterials, 23, 1553, 10.1016/S0142-9612(01)00267-8 · DOI · Paper page
  177. Yamazaki, 1990, Deformation and instability of membrane structure of phospholipid vesicles caused by osmophobic association, Biochemistry, 29, 1309, 10.1021/bi00457a029 · DOI
  178. Widder, 1980, In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres, Cancer Res, 40, 3512
  179. Gallo, 1989, Physiological pharmacokinetic model of adriamycin delivered via magnetic albumin microspheres in the rat, J Pharmacokinet Biopharm, 17, 305, 10.1007/BF01061899 · doi:10.1007/bf01061899
  180. Gallo, 1989, Evaluation of drug delivery following administration of magnetic albumin microspheres containing adriamycin to the rat, J Pharm Sci, 78, 190, 10.1002/jps.2600780303 · DOI
  181. Zimmermann, 1980, Development of drug carrier systems, Bioelectrochem Bioenerg, 7, 553, 10.1016/0302-4598(80)80014-6 · doi:10.1016/0302-4598(80)80014-6
  182. Freeman, 1965, Intestinal fat and iron transport, goblet cell mucus secretion, and cellular changes in protein deficiency observed with the electron microscope, Am J Dig Dis, 10, 1005, 10.1007/BF02233375 · doi:10.1007/bf02233375
  183. Meyers, 1966, Pathologic studies following magnetic control of metallic iron particles in the lymphatic and vascular system of dogs as a contrast and isotopic agent, Am J Roentgenol Radium Ther Nucl Med, 96, 913, 10.2214/ajr.96.4.913 · doi:10.2214/ajr.96.4.913
  184. Gallo, 1993, Targeting anticancer drugs to the brain, J Pharmacokinet Biopharm, 21, 575, 10.1007/BF01059115 · DOI
  185. Hirao, 2003, Targeted gene delivery to human osteosarcoma cells with magnetic cationic liposomes under a magnetic field, Int J Oncol, 22, 1065
  186. Choi, 2003, Surface modification of functional nanoparticles for controlled drug delivery, J Dispersion Sci Technol, 24, 2003
  187. PaÈuser, 1997, Liposome-encapsulated superparamagnetic iron oxide particles as markers in an MRI-guided search for tumor-specific drug carriers, Anticancer Drug Des, 12, 125
  188. Kubo, 2000, Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters, Int J Oncol, 17, 309
  189. Kubo, 2001, Targeted systemic chemotherapy using magnetic liposomes with incorporated adriamycin for osteosarcoma in hamsters, Int J Oncol, 18, 121
  190. Wilbanks, 1990, Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2-secreting B lymphocytes, Immunology, 71, 566
  191. Isabelle, 1997, Enhancement of cytokine expression in transiently transfected cells by magnetoliposome mediated hyperthermia, Cytotechnology, 25, 231
  192. Gupta, 2004, Surface modified superparamagnetic nanoparticles for drug delivery, J Mater Sci Mater Med, 15, 493, 10.1023/B:JMSM.0000021126.32934.20 · DOI · Paper page
  193. Najafi, 2003, Biodegradable micelles/polymersomes from fumaric/sebacic acids and poly(ethylene glycol), Biomaterials, 24, 1175, 10.1016/S0142-9612(02)00487-8 · DOI
  194. Otsuka, 2003, PEGylated nanoparticles for biological and pharmaceutical applications, Adv Drug Deliv Rev, 54, 403, 10.1016/S0169-409X(02)00226-0 · DOI · Paper page
  195. Chilkoti, 2002, Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery, Adv Drug Deliv Rev, 54, 1093, 10.1016/S0169-409X(02)00060-1 · DOI · Paper page
  196. Weissleder, 1995, Long circulating iron oxides for MR imaging, Adv Drug Deliv Rev, 16, 321, 10.1016/0169-409X(95)00033-4 · DOI · Paper page
  197. Johnson, 1993, Histology by magnetic resonance microscopy, Mag Reson, Q9, 1
  198. Fawell, 1994, Tat-mediated delivery of heterologous proteins into cells, Proc Natl Acad Sci USA, 91, 664, 10.1073/pnas.91.2.664 · DOI · Paper page
  199. Lewin, 2000, Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells, Nat Biotechnol, 18, 410, 10.1038/74464 · DOI · Paper page
  200. Weissleder, 2000, In vivo MR imaging of transgene expression, Nat Med, 6, 351, 10.1038/73219 · DOI · Paper page

200 of 231 shown

Cited by

See all 6,771

Metadata

Authors
Gupta, A. K., & Gupta, M.
Venue
Biomaterials
Publisher
Elsevier BV
Published
2005-06
Volume
26
Issue
18
Pages
3995-4021
ISSN
0142-9612 (ISSN-L)
OpenAlex
W2071659125
Cited by
6,771
References
4
FWCI
71.41
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. https://app.cochat.ai/papers/10.1016/j.biomaterials.2004.10.012
The paper
Gupta, A. K., & Gupta, M. (2005). Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. https://doi.org/10.1016/j.biomaterials.2004.10.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.